Diabetes in the Pediatric Surgical Patient

  • Ari J. Wassner
  • Michael S. D. AgusEmail author


Type 1 diabetes mellitus (T1DM) is one of the most common chronic diseases in children and is frequently encountered in pediatric surgical practice. The annual incidence of diabetes in the United States is about 1/4000 children, but the worldwide incidence varies markedly by geographic location and ethnicity. Diabetes will be encountered frequently in pediatric surgical practice, and familiarity with the principles of its pathophysiology, treatment, and potential complications is critical for providing optimal surgical care to these patients. Surgery in patients with diabetes is associated with a variety of special considerations and risks. Perioperative care of these patients requires an understanding of the pathophysiology and current treatment of this disease, which are reviewed in this chapter. Surgical planning, preoperative evaluation, and intraoperative and postoperative management are discussed in detail, including principles of glycemic control, insulin management, and nutrition. Relevant acute and chronic complications of diabetes are also discussed.


Pediatric diabetes Pediatric surgery Pediatric diabetes mellitus Perioperative glycemic control Surgery in diabetic patients 


  1. 1.
    Dabelea D, Bell RA, D’Agostino RB Jr, et al. Incidence of diabetes in youth in the United States. JAMA. 2007;297(24):2716–24.CrossRefPubMedGoogle Scholar
  2. 2.
    Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10(Suppl 12):3–12.CrossRefPubMedGoogle Scholar
  3. 3.
    Bolli GB, Fanelli CG. Physiology of glucose counterregulation to hypoglycemia. Endocrinol Metab Clin North Am. 1999;28(3):467–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Thunander M, Petersson C, Jonzon K, et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract. 2008;82(2):247–55.CrossRefPubMedGoogle Scholar
  5. 5.
    Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab. 2010;95(1):25–33.CrossRefPubMedGoogle Scholar
  6. 6.
    Betts P, Brink S, Silink M, et al. Management of children and adolescents with diabetes requiring surgery. Pediatr Diabetes. 2009;10(Suppl 12):169–74.CrossRefPubMedGoogle Scholar
  7. 7.
    Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRefGoogle Scholar
  8. 8.
    Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53.CrossRefPubMedGoogle Scholar
  9. 9.
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–9.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Rewers M, Pihoker C, Donaghue K, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2009;10(Suppl 12):71–81.CrossRefPubMedGoogle Scholar
  11. 11.
    Bangstad HJ, Danne T, Deeb L, et al. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2009;10(Suppl 12):82–99.CrossRefPubMedGoogle Scholar
  12. 12.
    Mehta SN, Wolfsdorf JI. Contemporary management of patients with type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):573–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Miles HL, Acerini CL. Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus. Paediatr Drugs. 2008;10(3):163–76.CrossRefPubMedGoogle Scholar
  14. 14.
    Polonsky KS, Given BD, Hirsch L, et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest. 1988;81(2):435–41.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.CrossRefPubMedGoogle Scholar
  16. 16.
    UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65.CrossRefGoogle Scholar
  17. 17.
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.CrossRefGoogle Scholar
  18. 18.
    Sigal RJ, Kenny GP, Wasserman DH, et al. Physical activity/exercise and type 2 diabetes. Diabetes Care. 2004;27(10):2518–39.CrossRefPubMedGoogle Scholar
  19. 19.
    Salpeter SR, Greyber E, Pasternak GA, et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010;4:CD002967.Google Scholar
  20. 20.
    Rosenbloom AL. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr. 2010;156(2):180–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Cruse PJ, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg. 1973;107(2):206–10.CrossRefPubMedGoogle Scholar
  22. 22.
    Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141(4):375–80.CrossRefPubMedGoogle Scholar
  23. 23.
    Noordzij PG, Boersma E, Schreiner F, et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol. 2007;156(1):137–42.CrossRefPubMedGoogle Scholar
  24. 24.
    Rhodes ET, Ferrari LR, Wolfsdorf JI. Perioperative management of pediatric surgical patients with diabetes mellitus. Anesth Analg. 2005;101(4):986–99.CrossRefPubMedGoogle Scholar
  25. 25.
    Bower WF, Lee PY, Kong AP, et al. Peri-operative hyperglycemia: a consideration for general surgery? Am J Surg. 2010;199(2):240–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.CrossRefPubMedGoogle Scholar
  28. 28.
    Branco RG, Garcia PC, Piva JP, et al. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med. 2005;6(4):470–2.CrossRefPubMedGoogle Scholar
  29. 29.
    Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr. 2005;146(1):30–4.CrossRefPubMedGoogle Scholar
  30. 30.
    Srinivasan V, Spinella PC, Drott HR, et al. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med. 2004;5(4):329–36.CrossRefPubMedGoogle Scholar
  31. 31.
    Tuggle DW, Kuhn MA, Jones SK, et al. Hyperglycemia and infections in pediatric trauma patients. Am Surg. 2008;74(3):195–8.PubMedGoogle Scholar
  32. 32.
    Wintergerst KA, Buckingham B, Gandrud L, et al. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics. 2006;118(1):173–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Palacio A, Smiley D, Ceron M, et al. Prevalence and clinical outcome of inpatient hyperglycemia in a community pediatric hospital. J Hosp Med. 2008;3(3):212–7.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Golden SH, Peart-Vigilance C, Kao WH, et al. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22(9):1408–14.CrossRefPubMedGoogle Scholar
  35. 35.
    Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22(10):607–12.CrossRefPubMedGoogle Scholar
  36. 36.
    Falcao G, Ulate K, Kouzekanani K, et al. Impact of postoperative hyperglycemia following surgical repair of congenital cardiac defects. Pediatr Cardiol. 2008;29(3):628–36.CrossRefPubMedGoogle Scholar
  37. 37.
    Polito A, Thiagarajan RR, Laussen PC, et al. Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery. Circulation. 2008;118(22):2235–42.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Preissig CM, Rigby MR, Maher KO. Glycemic control for postoperative pediatric cardiac patients. Pediatr Cardiol. 2009;30(8):1098–104.CrossRefPubMedGoogle Scholar
  39. 39.
    Ulate KP, Lima Falcao GC, Bielefeld MR, et al. Strict glycemic targets need not be so strict: a more permissive glycemic range for critically ill children. Pediatrics. 2008;122(4):e898–904.CrossRefPubMedGoogle Scholar
  40. 40.
    Yates AR, Dyke PC 2nd, Taeed R, et al. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med. 2006;7(4):351–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Duncan AE, Abd-Elsayed A, Maheshwari A, et al. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology. 2010;112(4):860–71.CrossRefPubMedGoogle Scholar
  42. 42.
    Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103(4):687–94.CrossRefPubMedGoogle Scholar
  43. 43.
    O’Brien JE, Jr., Marshall JA, Tarrants ML, et al. Intraoperative hyperglycemia and postoperative bacteremia in the pediatric cardiac surgery patient. Ann Thorac Surg 2010;89(2):578–583; discussion 583–4.Google Scholar
  44. 44.
    Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359–67.CrossRefPubMedGoogle Scholar
  45. 45.
    Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.CrossRefPubMedGoogle Scholar
  46. 46.
    Annane D, Cariou A, Maxime V, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303(4):341–8.CrossRefPubMedGoogle Scholar
  47. 47.
    Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36(12):3190–7.CrossRefPubMedGoogle Scholar
  48. 48.
    Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358(2):125–139.Google Scholar
  49. 49.
    Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.CrossRefPubMedGoogle Scholar
  50. 50.
    Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010;137(3):544–51.CrossRefPubMedGoogle Scholar
  51. 51.
    Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738–48.CrossRefPubMedGoogle Scholar
  52. 52.
    Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449–61.CrossRefPubMedGoogle Scholar
  53. 53.
    Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933–44.CrossRefPubMedGoogle Scholar
  54. 54.
    Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373(9663):547–56.CrossRefPubMedGoogle Scholar
  55. 55.
    Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, et al. SPECS study investigators. N Engl J Med 2012;367(13):1208–19. PMID:22957521.Google Scholar
  56. 56.
    Macrae D, Grieve R, Allen E, Sadique Z, Morris K, Pappachan J, Parslow R, et al. CHiP investigators. A randomized trial of hyperglycemic control in pediatric intensive care. N Engl J Med 2014;370(2):107–18. doi: 10.1056/NEJMoa1302564. Erratum in: N Engl J Med 2014;370(15):1469. PMID:24401049.
  57. 57.
    Agus MS, Wypij D, Hirshberg EL, Srinivasan V, Faustino EV, Luckett PM, et al. HALF-PINT study investigators and the PALISI network. Tight glycemic control in critically Ill children. N Engl J Med 2017. doi: 10.1056/NEJMoa1612348. [Epub ahead of print] PMID:28118549.
  58. 58.
    Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35(10):2262–7.CrossRefPubMedGoogle Scholar
  59. 59.
    Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233–43.CrossRefPubMedGoogle Scholar
  60. 60.
    Betts P, Brink S, Silink M, et al. Management of children and adolescents with diabetes requiring surgery. Pediatr Diabetes. 2009;10(Suppl 12):169–74.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2018

Authors and Affiliations

  1. 1.Department of PediatricsHarvard Medical School, Boston Children’s HospitalBostonUSA

Personalised recommendations